GNH USA

Europe — EMA

Olmesartán/Hidroclorotiazida Alter (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Alter, is an angiotensin II receptor blocker presented as a tablet for oral use.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Alter, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is indicated for adults. GNH USA supplies Olmesartán/Hidroclorotiazida Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán/Hidroclorotiazida Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmesartan/hydrochlorothiazide is used for managing high blood pressure through combined angiotensin receptor blockade and diuretic action.

- Hypertension: improves blood pressure control when monotherapy is insufficient. - Heart failure prevention: reduces risk of cardiovascular events in patients with hypertension. - Chronic kidney disease: aids in blood pressure management to slow disease progression. - Diabetes‑related hypertension: assists in achieving target blood pressures in diabetic patients. - Stroke risk reduction: contributes to lowering the likelihood of stroke in hypertensive individuals.

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

Common Side Effects: - Dizziness  - Headache  - Fatigue  - Increased urination  - Electrolyte imbalance (low potassium)  - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia - Angio‑edema - Liver function abnormalities - Blood cell disorders (e.g., agranulocytosis)

What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan/hydrochlorothiazide should be used with caution in patients with renal impairment, electrolyte disturbances, and hepatic dysfunction.

- Renal function monitoring: check serum creatinine and eGFR regularly. - Electrolyte assessment: monitor potassium and sodium levels. - Hepatic health: avoid use in severe liver disease. - Pregnancy: contraindicated in the second and  - Breastfeeding: discontinue  - Drug interactions: review  - Store at ambient: keep 

What does Olmesartan Medoxomil, Hydrochlorothiazide interact with?

The      ​  

g   t  t """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil, Hydrochlorothiazide
Route
Oral Use
Manufacturer
Laboratorios Alter, S.A.
Origin
EU

Related products